Controlled release of biologics for the treatment of type 2 diabetes.
about
Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015).Protective Mechanisms of the Mitochondrial-Derived Peptide Humanin in Oxidative and Endoplasmic Reticulum Stress in RPE Cells.Factors affecting the physical stability (aggregation) of peptide therapeutics.Oral delivery of biologics using drug-device combinations.Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.Visualization of the temperature dependent rearrangement of SynB1 elastin-like polypeptide on silica using scanning electron microscopyFluorescence Correlation Spectroscopy Reveals Efficient Cytosolic Delivery of Protein Cargo by Cell-Permeant Miniature Proteins
P2860
Q38838461-97565F8E-B452-496E-BE0A-98DB8E106E5DQ41319863-222C23BF-4370-4196-ABA2-38FE51C3BFD0Q46259884-8D63EF8C-7963-4D7E-8C71-50A9E740003FQ47830247-F11C8D86-3909-4169-82F2-E5BD2A5EB1EDQ49391770-EF2D35F3-403B-44C1-B610-96561D314CE4Q57356895-775F4DCA-0C9C-444A-BE62-3231654240FBQ58564633-B01738CF-C1CC-4512-9E33-8100848A76D6
P2860
Controlled release of biologics for the treatment of type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Controlled release of biologics for the treatment of type 2 diabetes.
@en
type
label
Controlled release of biologics for the treatment of type 2 diabetes.
@en
prefLabel
Controlled release of biologics for the treatment of type 2 diabetes.
@en
P2093
P2860
P1476
Controlled release of biologics for the treatment of type 2 diabetes.
@en
P2093
Ashutosh Chilkoti
Caslin A Gilroy
Kelli M Luginbuhl
P2860
P304
P356
10.1016/J.JCONREL.2015.12.002
P407
P577
2015-12-02T00:00:00Z